Neuroprotective effects of epoxyeicosatrienoic acids

Prostaglandins Other Lipid Mediat. 2018 Sep:138:9-14. doi: 10.1016/j.prostaglandins.2018.07.002. Epub 2018 Jul 18.

Abstract

Eicosatrienoic acids (EETs) are a class of intermediates produced during arachidonic acid metabolism mediated by cytochrome P450 epoxygenases that exert multiple physiological effects on the nervous system. EETs promote three metabolic processes, including esterification, hydrolysis and degradation or extension. EETs are hydrolyzed by soluble epoxide hydrolase (sEH) to form corresponding diols, thereby reducing their biological activity. Strategies regulating sEH expression or activity affect EET hydrolysis and alter relative cell concentrations, thus influencing EET function. This article summarizes the metabolic pathway of eicosatrienoic acid in organisms and highlights its neuroprotective effects on the central nervous system, which include regulating neuronal excitability, increasing cerebral blood flow, inhibiting neuronal apoptosis, reducing neuroinflammation, mitigating brain injury and promoting recovery of neurological function in subjects with nervous system diseases.

Keywords: Arachidonic acid; Cytochrome P450 epoxygenases; Eicosatrienoic acids; Nervous system; Neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / metabolism*
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Arachidonic Acid / metabolism*
  • Central Nervous System / cytology
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism*
  • Cerebrovascular Circulation / drug effects
  • Humans
  • Neurons / drug effects
  • Neurons / physiology
  • Neuroprotective Agents / metabolism*
  • Neuroprotective Agents / pharmacology

Substances

  • Neuroprotective Agents
  • Arachidonic Acid
  • 8,11,14-Eicosatrienoic Acid